Distribution details can be worked out in short order, too, I suspect. Obviously, we won’t be doing it ourselves, and there won’t be any shortage of willing partners. As for manufacturing, I’m feeling pretty good about Samsung Biologics. My concern is enrollment, enrollment, enrollment!